BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24992962)

  • 1. Long non-coding RNA INXS is a critical mediator of BCL-XS induced apoptosis.
    DeOcesano-Pereira C; Amaral MS; Parreira KS; Ayupe AC; Jacysyn JF; Amarante-Mendes GP; Reis EM; Verjovski-Almeida S
    Nucleic Acids Res; 2014 Jul; 42(13):8343-55. PubMed ID: 24992962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of alternative splicing of Bcl-x by BC200 contributes to breast cancer pathogenesis.
    Singh R; Gupta SC; Peng WX; Zhou N; Pochampally R; Atfi A; Watabe K; Lu Z; Mo YY
    Cell Death Dis; 2016 Jun; 7(6):e2262. PubMed ID: 27277684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RNA-binding protein Sam68 modulates the alternative splicing of Bcl-x.
    Paronetto MP; Achsel T; Massiello A; Chalfant CE; Sette C
    J Cell Biol; 2007 Mar; 176(7):929-39. PubMed ID: 17371836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis induces Bcl-XS and cleaved Bcl-XL in chronic lymphocytic leukaemia.
    Willimott S; Merriam T; Wagner SD
    Biochem Biophys Res Commun; 2011 Feb; 405(3):480-5. PubMed ID: 21256112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fyn requires HnRNPA2B1 and Sam68 to synergistically regulate apoptosis in pancreatic cancer.
    Chen ZY; Cai L; Zhu J; Chen M; Chen J; Li ZH; Liu XD; Wang SG; Bie P; Jiang P; Dong JH; Li XW
    Carcinogenesis; 2011 Oct; 32(10):1419-26. PubMed ID: 21642356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transcription factor FBI-1 inhibits SAM68-mediated BCL-X alternative splicing and apoptosis.
    Bielli P; Busà R; Di Stasi SM; Munoz MJ; Botti F; Kornblihtt AR; Sette C
    EMBO Rep; 2014 Apr; 15(4):419-27. PubMed ID: 24514149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-regulation of survival of motor neuron and Bcl-xL expression: implications for neuroprotection in spinal muscular atrophy.
    Anderton RS; Price LL; Turner BJ; Meloni BP; Mitrpant C; Mastaglia FL; Goh C; Wilton SD; Boulos S
    Neuroscience; 2012 Sep; 220():228-36. PubMed ID: 22732506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in cytosolic Ca2+ levels regulate Bcl-xS and Bcl-xL expression in spermatogenic cells during apoptotic death.
    Mishra DP; Pal R; Shaha C
    J Biol Chem; 2006 Jan; 281(4):2133-43. PubMed ID: 16301318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro-apoptotic effects of splice-switching oligonucleotides targeting Bcl-x pre-mRNA in human glioma cell lines.
    Li Z; Li Q; Han L; Tian N; Liang Q; Li Y; Zhao X; Du C; Tian Y
    Oncol Rep; 2016 Feb; 35(2):1013-9. PubMed ID: 26718027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative splicing of BCL-x is controlled by RBM25 binding to a G-quadruplex in BCL-x pre-mRNA.
    Le Sénéchal R; Keruzoré M; Quillévéré A; Loaëc N; Dinh VT; Reznichenko O; Guixens-Gallardo P; Corcos L; Teulade-Fichou MP; Granzhan A; Blondel M
    Nucleic Acids Res; 2023 Nov; 51(20):11239-11257. PubMed ID: 37811881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of BCLX pre-mRNA splicing has antitumor efficacy alone or in combination with radiotherapy in human glioblastoma cells.
    Dou Z; Lei H; Su W; Zhang T; Chen X; Yu B; Zhen X; Si J; Sun C; Zhang H; Di C
    Cell Death Dis; 2024 Feb; 15(2):160. PubMed ID: 38383492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. hnRNP A1/A2 and Sam68 collaborate with SRSF10 to control the alternative splicing response to oxaliplatin-mediated DNA damage.
    Cloutier A; Shkreta L; Toutant J; Durand M; Thibault P; Chabot B
    Sci Rep; 2018 Feb; 8(1):2206. PubMed ID: 29396485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric peptide nucleic acid compounds modulate splicing of the bcl-x gene in vitro and in vivo.
    Wilusz JE; Devanney SC; Caputi M
    Nucleic Acids Res; 2005; 33(20):6547-54. PubMed ID: 16299354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of Pnn expression results in mouse early embryonic lethality and cellular apoptosis through SRSF1-mediated alternative expression of Bcl-xS and ICAD.
    Leu S; Lin YM; Wu CH; Ouyang P
    J Cell Sci; 2012 Jul; 125(Pt 13):3164-72. PubMed ID: 22454513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl-xS and Bax induce different apoptotic pathways in PC12 cells.
    Lindenboim L; Yuan J; Stein R
    Oncogene; 2000 Mar; 19(14):1783-93. PubMed ID: 10777212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonistic effects of the SRp30c protein and cryptic 5' splice sites on the alternative splicing of the apoptotic regulator Bcl-x.
    Cloutier P; Toutant J; Shkreta L; Goekjian S; Revil T; Chabot B
    J Biol Chem; 2008 Aug; 283(31):21315-24. PubMed ID: 18534987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel PANDAR protein interaction partners involved in splicing regulation.
    Pospiech N; Cibis H; Dietrich L; Müller F; Bange T; Hennig S
    Sci Rep; 2018 Feb; 8(1):2798. PubMed ID: 29434205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the Apoptosis Gene Bcl-x Function Through Alternative Splicing.
    Stevens M; Oltean S
    Front Genet; 2019; 10():804. PubMed ID: 31552099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bax and Bcl-xs are induced at the onset of apoptosis in involuting mammary epithelial cells.
    Heermeier K; Benedict M; Li M; Furth P; Nuñez G; Hennighausen L
    Mech Dev; 1996 May; 56(1-2):197-207. PubMed ID: 8798158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular response to an antisense-mediated shift of Bcl-x pre-mRNA splicing and antineoplastic agents.
    Mercatante DR; Mohler JL; Kole R
    J Biol Chem; 2002 Dec; 277(51):49374-82. PubMed ID: 12381725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.